Next Generation Sequencing Market to Grow At a CAGR of 20.43% during the Period 2014 – 2023

Industry Trend Analysis:
In 2014, the Global Next Generation Sequencing Market was evaluated around USD 2.82 billion and is expected to reach approximately USD 15.04 billion by 2023 while registering itself at a compound annual growth rate (CAGR) of 20.43% over the forecast period.

Expansion of more rapid and efficient genomic sequencing methodologies is projected to fuel the NGS platforms adoption further and consequently regulating industrial expansion. Rising automation within the pre-sequencing protocols is projected to boost progress in the global industry in the approaching years. Use of innovative platforms for the growth of custom-made medicine by clinical analysis at a genetic stage is a major factor that is likely to improve NGS demand during the forecast years. An escalating amount of R&D projects in the areas of transcriptomics, metabolomics, and proteomics are anticipated to fuel the technology demand as well.

Genomics and proteomics function with and on a massive array of structural data that demands to be accumulated and classified through subsequent integrated data analysis and sequence determination. The introduction of novel services and products by well-known market giants is anticipated to boost the growth during the forecast years. Additionally, growing inclination of drug developers and scientists for the NGS technology in an attempt to employ the avenues of tailored medicine has established to be a high rise for demanding these platforms with the aim of gaining penetrations into the genetic enterprises of a huge amount of organisms. This augments in demand is expected to boost the NGS industry over the forecast period.

Get Sample Copy of This Report @ https://www.crystalmarketresearch.com/report-sample/HC02601 .

Market Classification:
Next Generation Sequencing (NGS) Market By Application, Estimates and Forecast, 2014-2023 ($Million)

Oncology
Clinical Investigation
Idiopathic Diseases
Inherited Diseases
Infectious Diseases
Non-Communicable / Other Diseases
Reproductive Health
NIPT
PGT
Newborn/Genetic Screening
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics

Next Generation Sequencing (NGS) Market By Technology, Estimates and Forecast, 2014-2023 ($Million)
Targeted Sequencing Analysis
DNA Based Targeted Sequencing Analysis
RNA Based Targeted Sequencing Analysis
Whole Genome Sequencing
Whole Exome Sequencing

Next Generation Sequencing (NGS) Market By Work-flow, Estimates and Forecast, 2014-2023 ($Million)
Pre-sequencing
NGS Library Preparation Kits
NGS Semi-Automated Library Preparation
NGS Automated Library Preparation
Clonal Amplification
Sequencing
Data Analysis
Primary Data Analysis
Secondary Data Analysis
Tertiary Data Analysis

Next Generation Sequencing (NGS) Market By End User, Estimates and Forecast, 2014-2023 ($Million)
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other Users

Application Outlook and Trend Analysis:
Application-wise NGS technology has profitable approaches in preimplantation and prenatal genetic screening, developmental oncology, HLA typing/immune system monitoring, epidemiology & drug development, metagenomics, agrigenomics & forensics, clinical investigation, and consumer genomics. Oncology is expected to demonstrate profitable growth in the approaching years owing to the speedily developing of sequencing capabilities that facilitate directed sequence determination of an amount of cancer genes that allow oncologists to acquire genetic data exist in few of the less available dense gene clusters concerning cancer tumors and cells.

Technology Outlook and Trend Analysis:
Targeted sequencing reported for the leading share due to the existence of numerous benefits linked with a minor dataset and decline in sequencing prices. Moreover, expansion in the amount of protein expression analysis projects is projected to rise due to the existence of DNA-based sequence data sets. Whole genome sequencing (WGS) includes de novo genome, microbial, and genome applications. It is anticipated to observe top year on year growth due to an amplified amount of research programs focused at mapping non-human and human whole genomes joint with decreasing WGS costs.

By Application:
Oncology
Clinical Investigation
Idiopathic Diseases
Inherited Diseases
Infectious Diseases
Non-Communicable / Other Diseases
Reproductive Health
NIPT
PGT
Newborn/Genetic Screening
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics

By Technology:
Targeted Sequencing Analysis
DNA Based Targeted Sequencing Analysis
RNA Based Targeted Sequencing Analysis
Whole Genome Sequencing
Whole Exome Sequencing

By Work flow:
Pre-sequencing
NGS Library Preparation Kits
NGS Semi-Automated Library Preparation
NGS Automated Library Preparation
Clonal Amplification
Sequencing
Data Analysis
Primary Data Analysis
Secondary Data Analysis
Tertiary Data Analysis

By End User:
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other Users

Browse Full Report @ https://www.crystalmarketresearch.com/report/next-generation-sequencing-ngs-market .

Research Methodology:
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

End User Outlook and Trend Analysis:
Usage of these solutions in R&D projects that are executed in the research centers and universities are prenominal for the leading share due to the existence of a huge amount of R&D projects. On-site bioinformatics courses provision which includes the workshops on the actual implementation of data analysis and NGS are also anticipated to fuel revenue produced via academic research in the approaching years. Rising NGS-based smaller scale platforms’ adoption for medical diagnostics is also a major end market projected to fuel demand during the future.

Table of Contents:
1.Introduction
2.Executive Summary
3.Market Overview
4.Next Generation Sequencing (NGS) Market, By Application
4.1.Introduction
4.2.Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Application (2014-2017)
4.2.1.Global Next Generation Sequencing (NGS) Sales and Sales Share By Application (2014-2017)
4.2.2.Global Next Generation Sequencing (NGS) Revenue and Revenue Share By Application (2014-2017)
4.3.Next Generation Sequencing (NGS) MarketAssessment and Forecast, By Application, 2014-2023
4.4.Oncology
4.4.1.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.Clinical Investigation
4.5.1.Market Assessment and Forecast, By Type, 2014-2023 ($Million)
4.5.2.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.3.Idiopathic Diseases
4.5.3.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.4.Inherited Diseases
4.5.4.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.5.Infectious Diseases
4.5.5.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5.6.Non-Communicable / Other Diseases
4.5.6.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.Reproductive Health
4.6.1.Market Assessment and Forecast, By Type, 2014-2023 ($Million)
4.6.2.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.3.NIPT
4.6.3.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.4.PGT
4.6.4.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6.5.Newborn/Genetic Screening
4.6.5.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.7.HLA Typing/Immune System Monitoring
4.7.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.8.Metagenomics, Epidemiology & Drug Development
4.8.1.arket Assessment and Forecast, By Region, 2014-2023 ($Million)
4.9.Agrigenomics & Forensics
4.9.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.10.Consumer Genomics
4.10.1.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.Next Generation Sequencing (NGS) Market, By Technology
5.1.Introduction
5.2.Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Technology (2014-2017)
5.2.1.Global Next Generation Sequencing (NGS) Sales and Sales Share By Technology (2014-2017)
5.2.2.Global Next Generation Sequencing (NGS) Revenue and Revenue Share By Technology (2014-2017)
5.3.Next Generation Sequencing (NGS) Market Assessment and Forecast, By Technology, 2014-2023
5.4.Targeted Sequencing Analysis
5.4.1.Market Assessment and Forecast, By Type, 2014-2023 ($Million)
5.4.2.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.4.3.DNA Based Targeted Sequencing Analysis
5.4.3.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.4.4.RNA Based Targeted Sequencing Analysis
5.4.4.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.5.Whole Genome Sequencing
5.5.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.6.Whole Exome Sequencing
5.6.1.Market Assessment and Forecast, By Region, 2014-2023 ($Million)

Competitive Outlook and Trend Analysis:
The major market players in global next-generation sequencing market are Beijing Genomics Institute, Pacific Biosciences, Knome Inc., F Hoffmann-La Roche, Thermo Fisher Scientific, GATC Biotech AG., Oxford Nanopore Technologies Inc., Biomatters Ltd., Agilent Technologies Inc., DNAStar Inc., Helicos BioSciences,CLC Bio (Qiagen), Macrogen Inc., and Illumina Inc. The rivalry between market players seeking to achieve a grip in the rapidly-developing biotech segment is engaging on numerous battlefields. Companies are concentrating on the advent of economical sequencing devices in regular healthcare checkups.

…..Continued

Avail Discount on Report @ https://www.crystalmarketresearch.com/check-discount/HC02601 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

Leave a Reply